Aptabio Therapeutics, Inc. (293780) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 18, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- -114.13
TBA (Not Confirmed)
Same Quarter Last Year
Aptabio Therapeutics, Inc. (KR:293780) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
KR:293780 Q2 2026 Earnings Report
KR:293780 Upcoming Earnings
Aptabio Therapeutics, Inc.'s next earnings date is estimated for November 18, 2026, based on past reporting schedules.
KR:293780 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | ―- | -114.13 | ― | ― | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―39.71 | -157.24 | 125.25% (+196.95) | ― | ― | |
| May 15, 2026 | 2026 (Q1) | ―-229.41 | -95.96 | -139.07% (-133.45) | ― | ― | |
| Mar 23, 2026 | 2025 (Q4) | ―-240.15 | -404.3 | 40.60% (+164.15) | ― | ― | |
| Nov 14, 2025 | 2025 (Q3) | ―-114.13 | -347.99 | 67.20% (+233.86) | ― | ― | |
| Aug 14, 2025 | 2025 (Q2) | ―-157.24 | -301.35 | 47.82% (+144.11) | ― | ― | |
| May 15, 2025 | 2025 (Q1) | ―-95.96 | -169.98 | 43.55% (+74.02) | ― | ― | |
| Mar 18, 2025 | 2024 (Q4) | ―-404.30 | -356.01 | -13.57% (-48.30) | ― | ― | |
| Nov 14, 2024 | 2024 (Q3) | ―-347.99 | -183.55 | -89.59% (-164.44) | ― | ― | |
| Aug 14, 2024 | 2024 (Q2) | ―-301.35 | -96.51 | -212.25% (-204.84) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
KR:293780 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 14, 2026 | ₩6,180.00 | ₩6,180.00 | +0.00% |
| May 15, 2026 | ₩6,930.00 | ₩6,740.00 | -2.74% |
| Mar 23, 2026 | ₩6,750.00 | ₩7,230.00 | +7.11% |
| Nov 14, 2025 | ₩7,830.00 | ₩7,790.00 | -0.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Aptabio Therapeutics, Inc. (KR:293780) report earnings?
Aptabio Therapeutics, Inc. (KR:293780) is estimated to report earnings on Nov 18, 2026, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.